v3 Template
G

GelSana

Biomaterials / Healthcare ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$3.1M
Funding Rounds
1
Last Funding
2023-11-30

About GelSana

GelSana Therapeutics is a Colorado-based biomaterials company focused on developing novel wound dressing materials to improve wound healing with reduced inflammation. Their mission is to provide innovative solutions for wound healing, including chronic wounds, through proprietary polymer chemistry.

Products & Services

Highly Elastic Wound Dressings:Innovative dressings that stretch across or conform to any wound, reduce inflammation, prevent infection, and provide sustained drug delivery over time.

Specialties

Wound Healing Polymer Chemistry Chronic Wound Solutions Inflammation Reduction Infection Prevention Sustained Drug Delivery

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Follow-on Investment
T: -
FT: Follow-on Investment 		A: 3100000
MR: -
FA: $3.1M
FAN: 3100000 		D: 2023-11-30
FD: 2023-11-30 		2 investors
Follow-on Investment Latest
2023-11-30
$3.1M
2 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Melissa Krebs

Founder and CEO

LinkedIn (Pro only)
J

Jon Fernandez

COO

LinkedIn (Pro only)
A

Adam Rocker

Director R&D

LinkedIn (Pro only)
B

Bikram Adhikari

Scientist I

A

Ania Camplin

Fractional CFO

M

Mike Freeman

Board Member

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

GelSana Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biomaterials / Healthcare
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro